| 1 | 169590-42-5 | 噻利考西 | Celecoxib | C17H14F3N3O2S
| 标准品;原料药;中间体;普通试剂;塞来昔布;塞来西布;神经信号;化学原药;抗关节炎;医药原料 | 成品药 |
| 2 | 544686-20-6 | Celecoxib-d4 | Celecoxib-d4 | C17H14F3N3O2S
| | |
| 3 | 54779-81-6 | Celecoxib IMpurity 1 | Celecoxib IMpurity 1 | C17H14F3N3O2S
| | |
| 4 | 131430-27-8 | 塞来昔布杂质 | Celecoxib Impurity 43 | C17H14F3N3O2S
| | |
| 5 | 170569-99-0 | 4-Desmethyl-2-methyl Celecoxib | 4-Desmethyl-2-methyl Celecoxib | C17H14F3N3O2S
| 化工原料;杂质对照品;对照品-杂质对照品 | |
| 6 | 331943-04-5 | 塞来昔布相关物质B | N-De(4-sulfonaMidophenyl)-N'-(4-sulfonaMidophenyl) Celecoxib | C17H14F3N3O2S
| 医药原料;杂质对照品;对照品-杂质对照品 | |
| 7 | | N-De(4-sulfonaMidophenyl)-N'-[4-sulfonaMido(phenyl-d4)] Celecoxib | N-De(4-sulfonaMidophenyl)-N'-[4-sulfonaMido(phenyl-d4)] Celecoxib | C17H14F3N3O2S
| Isotope Labelled Compounds;Pharmaceuticals;Aromatics;Heterocycles;Impurities;Inhibitors;Intermediates & Fine Chemicals | |
| 8 | 672950-09-3 | N-(2,3-DIMETHYL-6-QUINOXALINYL)-3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | N-(2,3-DIMETHYL-6-QUINOXALINYL)-3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | C17H14F3N3O2S
| | |
| 9 | 194044-54-7 | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de | C17H14F3N3O2S
| | |
| 10 | | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1h-pyrazole-1-yl] benzenesulfonamide | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1h-pyrazole-1-yl] benzenesulfonamide | C17H14F3N3O2S
| | |
| 11 | | N1-{4-[3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methylbenzene-1-sulfonamide | N1-{4-[3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methylbenzene-1-sulfonamide | C17H14F3N3O2S
| | |
| 12 | 356587-85-4 | 2-[(5-methoxy-1H-benzimidazol-2-yl)sulfanyl]-N-[3-(trifluoromethyl)phenyl]acetamide | 2-[(5-methoxy-1H-benzimidazol-2-yl)sulfanyl]-N-[3-(trifluoromethyl)phenyl]acetamide | C17H14F3N3O2S
| | |
| 13 | 1023873-02-0 | 4-(4-METHYLPHENYL)-3-((4-(TRIFLUOROMETHOXY)PHENOXY)METHYL)-1,2,4-TRIAZOLINE-5-THIONE | 4-(4-METHYLPHENYL)-3-((4-(TRIFLUOROMETHOXY)PHENOXY)METHYL)-1,2,4-TRIAZOLINE-5-THIONE | C17H14F3N3O2S
| | |
| 14 | 387831-23-4 | 3-amino-4,6-dimethyl-N-[4-(trifluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide | 3-amino-4,6-dimethyl-N-[4-(trifluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide | C17H14F3N3O2S
| | |
| 15 | 473445-31-7 | 2-(3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)-N-(2-((trifluoromethyl)thio)phenyl)acetamide | 2-(3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl)-N-(2-((trifluoromethyl)thio)phenyl)acetamide | C17H14F3N3O2S
| | |
| 16 | 956754-18-0 | N-([1-METHYL-5-PHENOXY-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL]METHYL)-2-THIOPHENECARBOXAMIDE | N-([1-METHYL-5-PHENOXY-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL]METHYL)-2-THIOPHENECARBOXAMIDE | C17H14F3N3O2S
| | |
| 17 | 255909-20-7 | 3-amino-N-(4-methoxyphenyl)-6-methyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide | 3-amino-N-(4-methoxyphenyl)-6-methyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide | C17H14F3N3O2S
| | |
| 18 | 955962-94-4 | METHYL 2-(2-[3-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-4-PHENYL-1,3-THIAZOL-5-YL)ACETATE | METHYL 2-(2-[3-METHYL-5-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-4-PHENYL-1,3-THIAZOL-5-YL)ACETATE | C17H14F3N3O2S
| | |
| 19 | | 2-{[3-cyano-4-(methoxymethyl)-6-methyl-2-pyridinyl]sulfanyl}-N-(2,3,4-trifluorophenyl)acetamide | 2-{[3-cyano-4-(methoxymethyl)-6-methyl-2-pyridinyl]sulfanyl}-N-(2,3,4-trifluorophenyl)acetamide | C17H14F3N3O2S
| | |
| 20 | 159885-68-4 | 5-甲基-1-{4-[3-三氟甲基)苯基]-1,3-噻唑-2-基}-1H-吡唑-4-羧酸乙酯 | 1H-Pyrazole-4-carboxylic acid, 5-methyl-1-[4-[3-(trifluoromethyl)phenyl]-2-thiazolyl]-, ethyl ester | C17H14F3N3O2S
| | |